Quintrio
Home

Stock overview

IM Cannabis Corp. Common Shares

IMCC

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.

Last trade $0.4818
Day change -$0.0132 (-2.67%)
Day range $0.45 – $0.4995
Volume 30,724
Market cap $1M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for IMCC.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for IMCC.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Whole Lotta Dank Debuts Dank Pack Across Alberta, Announces Nationwide Search for Cannabis Partners

Whole Lotta Dank, a Canadian cannabis brand development platform, officially launched Dank Pack, its first cannabis brand, with the debut product Blueberry BBL available across Alberta. The company is expanding its portfolio with 20+ SKUs under regulatory review and actively seeking long-term partnerships with Canadian cannabis producers, cultivators, and manufacturers. The launch is backed by eight retail locations and over 125,000 completed deliveries.

Benzinga

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

IM Cannabis Corp. (NASDAQ: IMCC) announced the closing of a US$225,000 convertible note financing with an institutional investor. The convertible note bears 8% interest (increasing to 14% upon default) and includes warrants to purchase 781,250 common shares at C$0.40 per share. The company intends to use net proceeds for general corporate purposes and has agreed to file a resale registration statement with the SEC.

Benzinga

IM Cannabis Corp. Announces First Quarter 2026 Financial Results

IM Cannabis Corp. (NASDAQ: IMCC) reported Q1 2026 results with revenues of $8.7 million, gross profit of $1.4 million, and a net loss of $2.5 million ($0.38 per share). The company reduced general and administrative expenses by 22% year-over-year and completed convertible note financings to support liquidity management. Operations continue in Israel and Germany with focus on cost optimization and strategic opportunities.

Benzinga

IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings

IM Cannabis Corp (NASDAQ: IMCC) announced the closing of convertible note financings totaling US$550,000 in gross proceeds. The company issued two convertible notes with warrants to institutional investors, with net proceeds to be used for general corporate purposes. The notes feature conversion prices tied to market conditions and include standard protective provisions for investors.

Benzinga

IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow

IM Cannabis Corp. reported 2025 full-year revenue of C$54.7 million with strong 134% growth in Germany, now representing 66% of total revenue. The company achieved positive operating cash flow of C$4.7 million, a significant turnaround from 2024, and strengthened its cash position to C$3.3 million through strategic financings. Additionally, IMC announced plans to diversify into defense technology through a proposed acquisition of 51% stake in Polish company Black Axe Technologies.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Aug 27, 20261-for-30reverse split
Jul 12, 20241-for-6reverse split
Nov 17, 20221-for-10reverse split